These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1528 related items for PubMed ID: 10690586

  • 21. [The malignant side of chronic inflammatory bowel disease].
    West RL, van de Vrie W, Schouten WR, van Dekken H, Kuipers EJ.
    Ned Tijdschr Geneeskd; 2002 Dec 28; 146(52):2521-4. PubMed ID: 12532661
    [Abstract] [Full Text] [Related]

  • 22. Review article: the effect of aminosalicylates and immunomodulation on cancer risk in inflammatory bowel disease.
    Stange EF.
    Aliment Pharmacol Ther; 2006 Oct 28; 24 Suppl 3():64-7. PubMed ID: 16961748
    [Abstract] [Full Text] [Related]

  • 23. Endoscopic screening for dysplasia and mucosal aneuploidy in adolescents and young adults with childhood onset colitis.
    Markowitz J, McKinley M, Kahn E, Stiel L, Rosa J, Grancher K, Daum F.
    Am J Gastroenterol; 1997 Nov 28; 92(11):2001-6. PubMed ID: 9362180
    [Abstract] [Full Text] [Related]

  • 24. Colon cancer in inflammatory bowel disease: recent trends, questions and answers.
    Viennot S, Deleporte A, Moussata D, Nancey S, Flourié B, Reimund JM.
    Gastroenterol Clin Biol; 2009 Jun 28; 33 Suppl 3():S190-201. PubMed ID: 20117342
    [Abstract] [Full Text] [Related]

  • 25. A high degree of aneuploidy, loss of p53 gene, and low soluble p53 protein serum levels are detected in ulcerative colitis patients.
    Rosman-Urbach M, Niv Y, Birk Y, Smirnoff P, Zusman I, Morgenstern S, Schwartz B.
    Dis Colon Rectum; 2004 Mar 28; 47(3):304-13. PubMed ID: 14991492
    [Abstract] [Full Text] [Related]

  • 26. Malignant transformation in inflammatory bowel disease - surveillance guide.
    Stallmach A, Bielecki C, Schmidt C.
    Dig Dis; 2009 Mar 28; 27(4):584-90. PubMed ID: 19897979
    [Abstract] [Full Text] [Related]

  • 27. Associated neoplastic disease in inflammatory bowel disease.
    Cendan JC, Behrns KE.
    Surg Clin North Am; 2007 Jun 28; 87(3):659-72. PubMed ID: 17560418
    [Abstract] [Full Text] [Related]

  • 28. Are dysplasia and colorectal cancer endoscopically visible in patients with ulcerative colitis?
    Rubin DT, Rothe JA, Hetzel JT, Cohen RD, Hanauer SB.
    Gastrointest Endosc; 2007 Jun 28; 65(7):998-1004. PubMed ID: 17451704
    [Abstract] [Full Text] [Related]

  • 29. Dysplasia and cancer in ulcerative colitis: a soluble problem?
    Riddell RH.
    Scand J Gastroenterol Suppl; 1984 Jun 28; 104():137-49. PubMed ID: 6597546
    [Abstract] [Full Text] [Related]

  • 30. Aberrant crypt foci as precursors of the dysplasia-carcinoma sequence in patients with ulcerative colitis.
    Kukitsu T, Takayama T, Miyanishi K, Nobuoka A, Katsuki S, Sato Y, Takimoto R, Matsunaga T, Kato J, Sonoda T, Sakamaki S, Niitsu Y.
    Clin Cancer Res; 2008 Jan 01; 14(1):48-54. PubMed ID: 18172251
    [Abstract] [Full Text] [Related]

  • 31. Dysplasia in inflammatory bowel disease.
    Greenson JK.
    Semin Diagn Pathol; 2002 Feb 01; 19(1):31-7. PubMed ID: 11936264
    [Abstract] [Full Text] [Related]

  • 32. [Tracing colorectal carcinoma in patients with inflammatory bowel disease].
    de Jong DJ, Nagengast FM.
    Ned Tijdschr Geneeskd; 2007 Dec 15; 151(50):2758-60. PubMed ID: 18232192
    [Abstract] [Full Text] [Related]

  • 33. Pericholangitis and sclerosing cholangitis are risk factors for dysplasia and cancer in ulcerative colitis.
    D'Haens GR, Lashner BA, Hanauer SB.
    Am J Gastroenterol; 1993 Aug 15; 88(8):1174-8. PubMed ID: 8338083
    [Abstract] [Full Text] [Related]

  • 34. Crohn's colitis: the incidence of dysplasia and adenocarcinoma in surgical patients.
    Maykel JA, Hagerman G, Mellgren AF, Li SY, Alavi K, Baxter NN, Madoff RD.
    Dis Colon Rectum; 2006 Jul 15; 49(7):950-7. PubMed ID: 16729218
    [Abstract] [Full Text] [Related]

  • 35. Immunohistochemical expression of P53 and oncogenes in ulcerative colitis-associated colorectal carcinoma.
    Brüwer M, Schmid KW, Senninger N, Schürmann G.
    World J Surg; 2002 Mar 15; 26(3):390-6. PubMed ID: 11865380
    [Abstract] [Full Text] [Related]

  • 36. Ursodeoxycholic acid treatment in IBD-patients with colorectal dysplasia and/or DNA-aneuploidy: a prospective, double-blind, randomized controlled pilot study.
    Sjöqvist U, Tribukait B, Ost A, Einarsson C, Oxelmark L, Löfberg R.
    Anticancer Res; 2004 Mar 15; 24(5B):3121-7. PubMed ID: 15510599
    [Abstract] [Full Text] [Related]

  • 37. Noncolorectal malignancies in inflammatory bowel disease: more than meets the eye.
    Beaugerie L, Sokol H, Seksik P.
    Dig Dis; 2009 Mar 15; 27(3):375-81. PubMed ID: 19786768
    [Abstract] [Full Text] [Related]

  • 38. Cancer in inflammatory bowel disease.
    Greenstein AJ.
    Mt Sinai J Med; 2000 May 15; 67(3):227-40. PubMed ID: 10828908
    [Abstract] [Full Text] [Related]

  • 39. Surveillance for dysplasia in patients with inflammatory bowel disease: a national survey of colonoscopic practice in New Zealand.
    Gearry RB, Wakeman CJ, Barclay ML, Chapman BA, Collett JA, Burt MJ, Frizelle FA.
    Dis Colon Rectum; 2004 Mar 15; 47(3):314-22. PubMed ID: 14991493
    [Abstract] [Full Text] [Related]

  • 40. Increased risk of colorectal cancer and dysplasia in patients with Crohn's colitis and primary sclerosing cholangitis.
    Lindström L, Lapidus A, Ost A, Bergquist A.
    Dis Colon Rectum; 2011 Nov 15; 54(11):1392-7. PubMed ID: 21979184
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 77.